ClinicalTrials.govpublic full text
To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
alzheimer disease, active immunization, antibody, central nervous system diseases, neurodegenerative diseases, vaccine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1029988
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.